Titre : | Fiabilidad del "Maudsley addiction profile" - MAP, ERIT-Version - y del "Treatment perceptions questionnaire" - TPQ - en Italia, Espana y Portugal para la evaluacion de tratamientos |
Titre traduit : | (Fiabilité du "Maudsley Addiction Profile" (MAP, ERIT-Version) et du "Treatment Perceptions Questionnaire" (TPQ) en Italie, Espagne et Portugal pour l'évaluation des traitements) ; (Fiability of the "Maudsley Addiction Profile" (MAP, ERIT-Version) and of the "Treatment Perceptions Questionnaire" (TPQ) in Italy, Spain and Portugal for the treatments evaluation) |
Auteurs : | J. MANDERSEN ; U. NIZZOLI ; C. CORBELLI ; H. MARGARON ; M. A. TORRES ; I. CASTRO DEL PRADO ; D. STEWART ; M. GOSSOP |
Type de document : | Périodique |
Année de publication : | 2001 |
Format : | 217-227 |
Note générale : |
Adicciones, 2001, 13, (2), 217-227
|
Langues: | Espagnol |
Discipline : | EPI (Epidémiologie / Epidemiology) |
Mots-clés : |
Thésaurus mots-clés ECHELLE D'EVALUATION ; FIABILITE ; TRAITEMENT ; EVALUATION ; VALIDITE ; QUESTIONNAIREThésaurus géographique ITALIE ; ESPAGNE ; PORTUGAL |
Résumé : | It describes the control that has been carried out on two new tools destined for research into the evaluation of treatments, the MAUDSLEY ADDICTION PROFILE (MAP ERIT-Version) and the TREATMENT PERCEPTIONS QUESTIONNAIRE (TPQ) in Italy, Portugal and Spain. The MAP and the TPQ were developed in the United Kingdom as fast, predictably valuable tools for research into the adult population that presents disorders derived from the use of psychoactive substances. The objective of this work was to validate the application of these tools in the context of the European continent, and the internal reliability and test-retest of the items. The study included 206 subjects in total (there were 124 who took part in the MAP test-retest and 95 who completed the TPQ). A further thirteen subjects were submitted to both the MAP and the TPQ. The results of the study indicate that the MAP can be applied in 15 minutes or even less; that the internal reliability and test-retest of the MAP and the TPQ is confirmed and that they are equally as ideal for the validation of the treatment as for other relevant research proposals that are being developed in the United Kingdom. (Review's abstract.) |
Domaine : | Drogues illicites / Illicit drugs |
Affiliation : |
Via Amendola, 2, 42100 Reggio Emilia Italie. Italy. |
Numéro Toxibase : | 1100934 |
Centre Emetteur : | 11 SEDAP |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil